US Physical Therapy Inc
F:UPH

Watchlist Manager
US Physical Therapy Inc Logo
US Physical Therapy Inc
F:UPH
Watchlist
Price: 67 EUR 0.75% Market Closed
Market Cap: €1B

Wall St Price Targets

UPH Price Targets Summary
US Physical Therapy Inc

Wall Street analysts forecast UPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UPH is 96.41 EUR with a low forecast of 87.51 EUR and a high forecast of 103.38 EUR.

Lowest Forecast
Price Target
87.51 EUR
31% Upside
Average Forecast
Price Target
96.41 EUR
44% Upside
Highest Forecast
Price Target
103.38 EUR
54% Upside
US Physical Therapy Inc Competitors:
Price Targets
HURN
Huron Consulting Group Inc
22% Upside

Revenue
Forecast

9% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
9% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 9%.

Gross Profit
Forecast

7% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
7% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 2 years is 11%.

Operating Income
Forecast

6% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
6% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 9%.

Pre-Tax Income
Forecast

6% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
6% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 6%. The projected CAGR for the next 3 years is 1%.

Net Income
Forecast

1% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss
1% / Year
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 39%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is UPH's stock price target?
Price Target
96.41 EUR

According to Wall Street analysts, the average 1-year price target for UPH is 96.41 EUR with a low forecast of 87.51 EUR and a high forecast of 103.38 EUR.

What is the Revenue forecast for US Physical Therapy Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 9%.

What is the Gross Profit forecast for US Physical Therapy Inc?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 2 years is 11%.

What is the Operating Income forecast for US Physical Therapy Inc?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 9%.

What is the Pre-Tax Income forecast for US Physical Therapy Inc?
Projected CAGR
1%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 6%. The projected CAGR for the next 3 years is 1%.

What is the Net Income forecast for US Physical Therapy Inc?
Projected CAGR
39%

Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 39%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett